Sign up for a free trial now
  • Login
  • Subscribe
  • Take a FREE Trial
  • About Us
  • Contact us
  • RSS

21 May 2013


The Pharma Letter
  • Home
  • 7 Day Premium Trial
  • Pharmaceuticals
  • Biotechnology
  • Generics
  • Events
  • Companies
  • Drugs
  • Subscribe

Flecainide Articles

Four drugmakers to pay $124 million for submission of false claims to USA’s Medicaid

20 October 2009

US sales almost triple for Meda in 2008

2 March 2009

Stock Commentary - New York - week to Oct 1, 2007

8 October 2007

Japan stock market week to July 2, 2007

9 July 2007

Japan to promote pediatric acetaminophen

15 January 2007

3M pulls out of branded pharma, selling the business in three-part $2.1B deals

20 November 2006

3M explores options for pharma business

10 April 2006

Japan to discuss pediatric drug use

10 April 2006

Ranbaxy gets OK for generic Tambocor

7 April 2003

Indian Drug Co Looks For Merger Boost

5 February 1998

Amiodarone Cuts Total Mortality Post-MI, CHF

12 June 1997

KNOLL'S RYTHMOL BACKED BY FDA PANEL

4 April 1994

SOTALOL BEST, SAYS ARRHYTHMIA STUDY

27 April 1992

CAST EFFECTS ON ANTI-ARRHYTHMICS

20 January 1992

Showing 1-14 of 14 articles

Go to beginningPrevious
  • 1
NextGo to end
  • Hot Topics
  • Most Read
  • Elan makes "transformational" acquisitions and a divestment
  • Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
  • SciClone gains China rights to Zensun's Neucardin
  • Bristol-Myers' data on Yervoy and nivolumab causes a stir
  • Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
  • Elan makes "transformational" acquisitions and a divestment
  • Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
  • SciClone gains China rights to Zensun's Neucardin
  • Bristol-Myers' data on Yervoy and nivolumab causes a stir
  • Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member

30 Day Premium Trial


Events

Twitter Right banner

RSS



© 2013 thepharmaletter.com

  • Home
  • RSS
  • About Us
  • Subscribe
  • Terms and Conditions
  • Article Archive
Site powered by WORKSsitebuilder CMS